4.1 Review

Predictors of Postpartum Depression: A Comprehensive Review of the Last Decade of Evidence

Journal

CLINICAL OBSTETRICS AND GYNECOLOGY
Volume 61, Issue 3, Pages 591-603

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/GRF.0000000000000368

Keywords

postpartum depression; predictors; molecular; biomarker; risk assessment

Funding

  1. National Institutes of Mental Health [4T32MH093315-05, R01MH104468]
  2. Sage Therapeutics
  3. Janssen

Ask authors/readers for more resources

Postpartum depression (PPD) is one of the most frequent complications of childbirth affecting similar to 500,000 women annually (prevalence 10% to 15%). Despite the documented adverse outcomes for mother and child, there remains a great need to develop prospective approaches to identify women at risk. This review examines some of the best-characterized molecular and clinical risk factors for PPD. We illustrate that this is a growing literature but there remains a lack of reliable molecular predictors for PPD. Current best predictors are clinical assessments for psychiatric history and adverse life events, highlighting the need for increased depression screening across the perinatal period.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available